Dr. Neama Said Abdel, the World Health Organization (WHO) Representative in Egypt, emphasized that universal health insurance is a fundamental human right, and Egypt is actively working towards innovative solutions …
Health
-
-
Dr. Khaled Abdel Ghaffar, Deputy Prime Minister and Minister of Health and Population, highlighted Egypt’s commitment to localizing the production of pharmaceutical products, especially vaccines, by leveraging global expertise …
-
The European Bank for Reconstruction and Development (EBRD) has fully exited its remaining 8.8% stake in Ibnsina Pharma through the Egyptian Exchange (EGX). This marks the conclusion of the bank’s …
-
HealthHighlights
Egypt’s Drug Authority Head Joins Opening of the 2nd Forum for Vaccine and Health Product Manufacturers in African Union States
Dr. Ali Al-Ghamrawy, Head of Egypt’s Drug Authority, participated in the launch of the 2nd Vaccine and Health Product Manufacturers Forum for African Union member states, held from February 4 …
-
HealthHighlights
EVA Pharma, DNA Script, and Quantoom Forge Partnership to Revolutionize RNA-based Vaccines and Therapeutics Production
Egypt’s EVA Pharma, France’s DNA Script, and Belgium’s Quantoom Biosciences have today signed a Memorandum of Understanding (MoU) at the 2nd Vaccine and Health Products Manufacturing Forum for African Union …
-
HealthHighlightsNews
NCCM, in collaboration with UNICEF, Hosts Roundtable on “Girls’ Health in Egypt”
The National Council for Childhood and Motherhood (NCCM), in collaboration with UNICEF, held a roundtable discussion titled “Girls’ Health in Egypt”. The event aimed to set forth a policy framework …
-
HealthHighlights
Minister of Social Solidarity Launches Drug Protection Program Results in Developed Areas
Minister of Social Solidarity and Chairperson of the Anti-Addiction and Abuse Fund, Dr. Maya Morsy, recently attended the announcement of the results of the “Drug Protection Program in Developed Areas …
-
RMBV (RMBV Private Equity), based in the Netherlands, plans to invest $100 million in the Egyptian market in 2025. This investment will focus on acquiring minority stakes in 4 …
-
The top 10 foreign pharmaceutical companies operating in Egypt achieved sales of 60 billion EGP in 2024, accounting for 28% of the total drug sales in the country last …
-
Egypt has marked a significant milestone in its healthcare system with the nationwide launch of “Trikafta,” a groundbreaking gene therapy for children diagnosed with cystic fibrosis. This new treatment, …
